Oppenheimer analyst issues PERFORM recommendation for PATH on December 1, 2023 11:17AM ET. The previous analyst recommendation was Perform.PATH was trading at $24.985 at issue of the analyst recommendation.The overall...
Needham analyst issues BUY recommendation for PATH on December 1, 2023 11:17AM ET. The previous analyst recommendation was Buy.PATH was trading at $24.985 at issue of the analyst recommendation.The overall...
BMO Capital analyst issues PERFORM recommendation for PATH on December 1, 2023 11:17AM ET. The previous analyst recommendation was Perform.PATH was trading at $24.985 at issue of the analyst recommendation.The...
Citigroup analyst issues BUY recommendation for CRM on November 30, 2023 07:21AM ET. The previous analyst recommendation was Buy.CRM was trading at $230.35 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues BUY recommendation for BIDU on November 29, 2023 01:14PM ET. The previous analyst recommendation was Buy.BIDU was trading at $118.31 at issue of the analyst recommendation.The...
Goldman Sachs analyst issues BUY recommendation for CRWD on November 29, 2023 10:25AM ET. The previous analyst recommendation was Buy.CRWD was trading at $231.37 at issue of the analyst recommendation.The...
Oppenheimer analyst issues OUTPERFORM recommendation for CRWD on November 29, 2023 10:25AM ET. The previous analyst recommendation was Outperform.CRWD was trading at $231.37 at issue of the analyst recommendation.The overall...
Mizuho Securities analyst issues BUY recommendation for CRWD on November 29, 2023 10:25AM ET. The previous analyst recommendation was Buy.CRWD was trading at $231.37 at issue of the analyst recommendation.The...
Citigroup analyst issues OVERWEIGHT recommendation for CRM on November 29, 2023 09:49AM ET. The previous analyst recommendation was Overweight.CRM was trading at $229.05 at issue of the analyst recommendation.The overall...
Citigroup analyst issues NEUTRAL recommendation for CRM on November 29, 2023 09:49AM ET. The previous analyst recommendation was Neutral.CRM was trading at $229.05 at issue of the analyst recommendation.The overall...
